Patents for C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967) |
---|
10/01/2008 | CN100422158C Inhibitors of Akt activity |
09/25/2008 | US20080234276 Heterocyclic Triazines as Hypoxic Selective Protein Kinase Inhibitors |
09/24/2008 | EP1809615A4 Lamotrigine analogs |
09/24/2008 | CN101273020A NNRT inhibitors |
09/17/2008 | EP1970373A1 Alicyclic heterocyclic compound |
09/17/2008 | EP1254122B1 Novel 3-substituted 1,2,4-benzotriazines, a method for their production and the use thereof |
09/17/2008 | CN101265238A Method for synthesizing triazine ring derivatives |
09/16/2008 | US7425629 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols |
09/16/2008 | US7425561 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
09/11/2008 | US20080221108 Anthranilic Acid Derivatives As Hm74A Receptor Agonists |
08/20/2008 | EP1957485A2 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
08/20/2008 | CN100412064C Malononitrile compounds and its use |
08/14/2008 | US20080194583 Tubulin Inhibitors |
08/14/2008 | US20080194565 5-Phenyl-Pentanoic Acid Derivatives as Matrix Metalloproteinase Inhibitors for the Treatment of Asthma and Other Diseases |
08/12/2008 | US7410968 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects |
08/05/2008 | US7407956 Benzamide inhibitors of the P2X7 receptor |
07/30/2008 | CN101230045A Aromatic triazin derivatives and uses thereof |
07/23/2008 | EP1597242B1 Hiv inhibiting 1,2,4-triazines |
07/17/2008 | WO2008056257A3 Novel triazinedione derivatives as gaba-b receptor modulators |
07/17/2008 | US20080171741 e.g. 5-(4-Chlorophenyl)-N-(5-(cyclopropylcarbamoyl)-2-methylphenyl)furan-2-carboxamide; p38 alpha and beta kinase inhibitor; antiinflammatory agent; asthma, inflammatory bowel disease, osteoporosis, psoriasis, graft vs. host rejection, atherosclerosis, multiple myeloma, pain, myocardial ischemia |
07/16/2008 | CN101219987A New nitrogen-containing heterocyclic derivative and organic electroluminescent element using the same |
07/10/2008 | US20080167313 Antidiabetic agents; dyslipidemia; hhypoglycemic agents; atherosclerosis ; obesity; antiinflammatory agents; metabolism disorders |
07/10/2008 | US20080167287 Imidazotriazines and imidazopyrimidines as kinase inhibitors |
07/08/2008 | US7396850 Pyrazole derivative as PPAR modulator |
07/02/2008 | EP1937651A1 Nnrt inhibitors |
07/01/2008 | US7393667 Using oxidoreductase enzyme to convert ketones to chiral alcohols; precursors inhibitors of vascular endothelial growth factor receptor-2, useful as an anticancer agent |
06/24/2008 | US7390899 Process for the synthesis of high purity 3,5-diamino-6-(2,3-dichlorophenyl) (1,2,4-triazine) |
06/24/2008 | US7390807 Crystal forms of lamotrigine and processes for their preparations |
06/24/2008 | US7390806 Antibiotics containing borinic acid complexes and methods of use |
06/18/2008 | EP1931460A2 Stabilization of organogels and hydrogels by azide-alkyneý2+3¨cycloaddition |
06/18/2008 | EP1458692B1 A new and efficient process for the preparation of lamotrigine and related 3,5-diamino-6-substituted-1,2,4-triazines |
06/12/2008 | WO2008070134A1 Inhibitors of akt activity |
06/12/2008 | US20080139811 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection |
06/12/2008 | US20080139808 Crystal forms of lamotrigine and processes for their preparations |
06/12/2008 | US20080139565 Anthranilic Acid Derivatives and Their Use in Treatment of Diseases of Lipid Metabolism, in Particular Dyslipidaemia |
06/12/2008 | US20080138283 1,2,4-triazole- 3,5-dione derivatives; for imaging and therapy of psychiatric, eating, sleeping, bipolar disorder; anxiolytic agent, antidepressant; Alzheimer's, Parkinson's diseases, epilepsy; imaging agents for a serotonin receptor |
06/12/2008 | CA2670767A1 Inhibitors of akt activity |
06/12/2008 | CA2659895A1 Improved method for synthesizing lamotrigine |
06/05/2008 | US20080132706 Compounds as PDE IV and TNF Inhibitors |
06/04/2008 | EP1204643B1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
05/29/2008 | US20080125433 Method of treating hair loss using thyromimetic compounds |
05/28/2008 | CN101189214A Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides |
05/22/2008 | WO2008059259A2 Anticancer compounds with a benzo ( 1, 2, 4 ) triazin-3yl-amine core |
05/15/2008 | US20080114169 Intermediates of active esters for peptide synthesis, labeling, analysis; purity |
05/15/2008 | CA2668853A1 Novel triazinedione derivatives as gaba-b receptor modulators |
05/13/2008 | US7371750 Compounds and compositions as protein kinase inhibitors |
05/08/2008 | WO2007122638B1 An improved process for preparation of lamotrigine intermediates |
05/08/2008 | DE102006049618A1 Triazine und Ihre Verwendung als Metalloproteinase-Inhibitoren Triazines and their use as metalloproteinase inhibitors |
05/07/2008 | EP1328275B1 Substituted 4,5-dihydro-1,2,4-triazin-3-ones, 1,2,4-triazin-3-ones, and their use as fungicides and insecticides |
05/06/2008 | US7368453 Quinazolinone compounds with reduced bioaccumulation |
05/06/2008 | CA2244979C Proton conductor in liquid form |
04/30/2008 | CN100384423C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
04/24/2008 | WO2008046657A1 Triazines and their use as inhibitors of metalloproteinases |
04/24/2008 | US20080096891 Triazine derivatives, their preparation and therapeutic application thereof |
04/23/2008 | EP1054875B1 Insecticidal dihydro-oxadiazines, -thiadiazines and -triazines |
04/17/2008 | WO2008044688A1 Urea derivative |
04/17/2008 | DE10234188B4 Oktupolare Moleküle als organische Halbleiter Octupolar molecules as organic semiconductors |
04/02/2008 | CN101155790A 1,2,4-triazine derivatives, preparation and use thereof in human therapy |
03/27/2008 | US20080076921 Inhibitors of bruton's tyrosine kinase |
03/26/2008 | EP1509218A4 Peptide deformylase inhibitors |
03/19/2008 | EP1363630B1 Kappa opioid receptor ligands |
03/13/2008 | WO2008030843A1 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity |
03/13/2008 | WO2008030838A2 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist biological activity |
03/13/2008 | WO2007122638A3 An improved process for preparation of lamotrigine intermediates |
03/13/2008 | US20080064872 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist biological activity |
03/13/2008 | CA2662852A1 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity |
03/13/2008 | CA2662850A1 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist biological activity |
03/12/2008 | CN100374425C Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers |
03/06/2008 | US20080058337 Pyrrolotriazine kinase inhibitors |
02/21/2008 | WO2008019798A1 A process for the preparation of lamotrigine |
02/21/2008 | US20080045536 Fused heterocyclic compounds useful as kinase modulators |
02/21/2008 | CA2659290A1 A process for the preparation of lamotrigine |
02/12/2008 | US7329757 Chloroazinium compounds: 2-chloro-5-methyl-1-(3-trifluoromethyl-phenyl)-pyridinium chloride; intermediates for preparting iminoazine herbicides: N-cyclopropyl-5-methyl-1-(3-trifluoromethylphenyl)-2(1H)-pyridineimine |
02/07/2008 | WO2008015429A2 Pharmaceutical compounds |
02/05/2008 | CA2339272C Nitrogen-containing heterocyclic carboxamide derivatives or salts thereof and antiviral agents comprising the same |
01/31/2008 | US20080027037 Cyclic compounds |
01/30/2008 | EP1881966A2 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-trianzin-6-ones, and their use as fungicides |
01/24/2008 | US20080020985 Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof |
01/24/2008 | DE102006032107A1 Neue aromatische Aza-Heterocyclen, Herstellungsverfahren dazu und Verwendung des Materials in der organischen Elektronik New aromatic aza-heterocycles, manufacturing method thereof and use of the material in organic electronics |
01/17/2008 | WO2008006738A1 Novel aromatic aza heterocycles, method of production and use of the material in organic electronics |
01/17/2008 | US20080015195 Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase |
01/10/2008 | WO2008003141A1 Therapeutic compounds |
01/10/2008 | US20080009620 Tricyclic Spacer Systems For Nonlinear Optical Devices |
01/10/2008 | CA2656851A1 Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity |
01/09/2008 | EP1874761A2 4h-1,2,4-triazin-5-one derivatives, their preparation and their use as alpha 7 nicotinic acetylcholine receptors |
01/01/2008 | US7314876 Administering to mammals nitrogen compounds, as mitogen activated kinase inhibitors, for prophylaxis asthma, respiratory system disorders, graft versus host disease, atherosclerosis and arthritis |
12/27/2007 | US20070299075 e.g. 1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-4-(aminosulfonyl)aminobutan-2-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent |
12/26/2007 | CN101094838A Tubulin binding anticancer agents and prodrugs thereof |
12/19/2007 | EP1866292A1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments |
12/19/2007 | EP1664031B1 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors |
12/12/2007 | CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
12/11/2007 | US7307169 Isotopically enriched N-substituted piperazines and methods for the preparation thereof |
12/06/2007 | WO2007138075A1 Method for preparing lamotrigine and its intermediate 2,3-dichlorobenzoyl chloride |
12/06/2007 | US20070281939 5-(3,5-Dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(1-hydroxy-cycloheptylmethyl)benzamide derivatives in which the triazine ring has various 4-substituents, e.g., carbamoylmethyl-, dimethylaminoethyl-, acetylaminoethyl-, and pyridinylmethyl-; treating rheumatoid arthritis |
12/05/2007 | CN100352819C Novel compounds as NS3-serine protease inhibitors of hepatitis c virus |
12/04/2007 | US7304063 Inhibitors of Akt activity |
11/29/2007 | CA2650611A1 Compositions and methods for fgf receptor kinases inhibitors |
11/27/2007 | US7301021 Substituted imidazole compounds |
11/22/2007 | US20070270416 Active Compound Combinations Having Insecticidal and Acaricidal Properties |